A recent study indicated that T-cell effector cytokines IFN-γ and TNF-α induced cytokine and chemokine secretion from NSCLC patient-derived CAFs in vitro, which may affect immune cell recruitment and activation and, ultimately, tumor progression and treatment response [165]. Here, TNF is linked to neoplasm.